IDEXX LABORATORIES INC /DE (IDXX)
Healthcare · In Vitro & In Vivo Diagnostic Substances
IDEXX LABORATORIES INC /DE (IDXX) stock research on InvestAtlant: institutional ownership from 13F filings, insider Form 4 activity, and SEC context.
Top institutional holders (2026-Q3)
| Institution | Shares | Value | % Outstanding |
|---|---|---|---|
| Pictet Asset Management Holding SA | 1,142,448 | $260.47M | 1.45% |
| FENIMORE ASSET MANAGEMENT INC | 772,862 | 76.20M | 0.98% |
| FLOSSBACH VON STORCH SE | 630,101 | 39.73M | 0.80% |
| Boston Trust Walden Corp | 380,812 | $84.72M | 0.48% |
| Alecta Tjanstepension Omsesidigt | 379,500 | $86.53M | 0.48% |
| Sumitomo Mitsui Trust Group, Inc. | 346,083 | $35.81M | 0.44% |
| DEPRINCE RACE & ZOLLO INC | 272,218 | $62.06M | 0.35% |
| Robeco Institutional Asset Management B.V. | 262,412 | $59.82M | 0.33% |
Recent insider transactions
| Date | Insider | Title | Type | Value |
|---|---|---|---|---|
| 2026-09-04 | Kingsley Lawrence D | Director | Sale | .17M |
| 2026-03-03 | Hunt Nimrata | Executive Vice President | Sale | .12M |
| 2026-02-26 | MAZELSKY JONATHAN JAY | President and CEO, Director | Sale | $713.4K |
| 2026-02-26 | MAZELSKY JONATHAN JAY | President and CEO, Director | Sale | .09M |
| 2026-02-26 | MAZELSKY JONATHAN JAY | President and CEO, Director | Sale | $765.5K |
| 2026-02-26 | MAZELSKY JONATHAN JAY | President and CEO, Director | Sale | $727.3K |
| 2026-02-26 | MAZELSKY JONATHAN JAY | President and CEO, Director | Sale | $975.9K |
| 2026-02-26 | MAZELSKY JONATHAN JAY | President and CEO, Director | Sale | $882.1K |